STTK
Shattuck Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.01
+2.74%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2098.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.86x
- Price / sales
- 603.18x
- Price / cash flow
- -14.70x
Enterprise value
- Enterprise value
- $542.6M
- EV / sales
- 542.56x
- EV / EBITDA
- -11.20x
- EV / EBIT
- -9.73x
- Market cap
- $603.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026